clinical trials Archives

Clinical trials change Arizona’s bioscience, business sectors


Last November, Arizona voters resoundingly passed Prop. 303 making it legal in Arizona for companies and physicians to provide terminally ill patients the “right to try” investigational drugs or therapies outside an FDA approved clinical trial.    While it sounded good in the short description provided to voters, in reality, it is unlikely to provide… Read More →

CTCA Opening New Set of Clinical Trials

clinical research advantage - vaccines

Cancer Treatment Centers of America® (CTCA) at Western Regional Medical Center (Western) in Goodyear announced it will launch 12 additional industry-sponsored clinical trials from now through December 2014. New trials will include both Phases I and II studies seeking to provide treatment options for multiple cancer types, including pancreatic, lung, prostate, colorectal and bladder. “These… Read More →

Gordon named clinical trials medical director

Michael Gordon MD

Michael S. Gordon, MD, one of the greater Phoenix area’s leading medical oncologists and cancer researchers, has been named the new Medical Director for the Virginia G. Piper Cancer Center Clinical Trials program at Scottsdale Healthcare. Dr. Gordon will oversee the center’s internationally recognized Phase I clinical trials program, which is known for its leadership… Read More →

TGen-TD2-Scottsdale Healthcare study benefits patients


The Side-Out Foundation’s breast cancer pilot study, led by the Translational Genomics Research Institute (TGen), Translational Drug Development (TD2) and Scottsdale Healthcare, has shown that cancer patients do better when their treatment is guided by molecular profiling. Specifically, 52 percent of patients with advanced breast cancer received clinical benefit – meaning their disease was controlled… Read More →

FDA approved thyroid cancer drug tested by TGen

by in Bioscience | Featured | Healthcare

The FDA has approved a thyroid cancer drug successfully tested at Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute (TGen). The U.S. Food and Drug Administration approved cabozantinib for the treatment of progressive, metastatic medullary thyroid cancer (MTC), a rare endocrine gland cancer affecting the… Read More →

CRA forms alliance with Quintiles

Mark H pics 001
by in Business News | Healthcare | Tech

Tempe-based Clinical Research Advantage (CRA), the country’s largest community-based network of clinical trial sites, has entered into a strategic agreement  with Quintiles to facilitate a higher level of clinical trial participation with an emphasis on safety, improved study efficiencies and excellent quality data in medical research. Clinical Research Advantage is the first therapeutically aligned network… Read More →

Tempe’s CRA acquires Radiant Research

by in Business News | Healthcare | Tech

Tempe-based CRA Holdings, LLC announced that it has acquired Radiant Research, Inc. CRA Holdings is the company that also owns Clinical Research Advantage (CRA), another major player in the SMO market. By combining these two entities under the same investment portfolio, the organizations collectively have 57 sites with more than 550 research professionals and an… Read More →

Clinical Research Advantage Receives 5 STEVIE Awards

clinical research advantage

Tempe-based Clinical Research Advantage, a community-based network of clinical trial sites, was honored with three Silver and two Bronze STEVIE Awards at the 10th Annual American Business Awards held on June 18th in New York City. The American Business Awards are the nation’s premier business awards program. This year, more than 3,000 nominations from organizations of… Read More →